229 related articles for article (PubMed ID: 14569203)
1. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging.
Askanas V; Engel WK
Curr Opin Rheumatol; 2003 Nov; 15(6):737-44. PubMed ID: 14569203
[TBL] [Abstract][Full Text] [Related]
2. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
3. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
4. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.
Askanas V; Engel WK
Curr Opin Neurol; 2002 Oct; 15(5):525-31. PubMed ID: 12351995
[TBL] [Abstract][Full Text] [Related]
5. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
8. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
Askanas V; Engel WK
Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
[TBL] [Abstract][Full Text] [Related]
9. Sporadic inclusion-body myositis: a proposed key pathogenetic role of the abnormalities of the ubiquitin-proteasome system, and protein misfolding and aggregation.
Askanas V; Engel WK
Acta Myol; 2005 Jul; 24(1):17-24. PubMed ID: 16315367
[TBL] [Abstract][Full Text] [Related]
10. Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging.
Askanas V; Engel WK
J Child Neurol; 2003 Mar; 18(3):185-90. PubMed ID: 12731644
[TBL] [Abstract][Full Text] [Related]
11. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation.
Askanas V; Engel WK; Nogalska A
Brain Pathol; 2009 Jul; 19(3):493-506. PubMed ID: 19563541
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
13. Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.
Askanas V; Engel WK; Nogalska A
Biochim Biophys Acta; 2015 Apr; 1852(4):633-43. PubMed ID: 25241263
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.
Fratta P; Engel WK; McFerrin J; Davies KJ; Lin SW; Askanas V
Am J Pathol; 2005 Aug; 167(2):517-26. PubMed ID: 16049336
[TBL] [Abstract][Full Text] [Related]
15. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.
Askanas V; Engel WK
Curr Rheumatol Rep; 2002 Oct; 4(5):427-33. PubMed ID: 12217248
[TBL] [Abstract][Full Text] [Related]
16. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Askanas V; Engel WK
Curr Opin Rheumatol; 1995 Nov; 7(6):486-96. PubMed ID: 8579968
[TBL] [Abstract][Full Text] [Related]
17. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]